LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI

被引:0
|
作者
Agnello, Francesco [1 ]
Cannella, Roberto [1 ]
Brancatelli, Giuseppe [1 ]
Galia, Massimo [1 ]
机构
[1] Univ Palermo, Dept Radiol, Policlin Paolo Giaccone, Via Vespro 127, I-90127 Palermo, Italy
来源
RADIOLOGIA MEDICA | 2024年 / 129卷 / 11期
关键词
LI-RADS; CT; MRI; Liver; Contrast media; GD-EOB-DTPA; FOCAL LIVER-LESIONS; SMALL HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; DELAYED PHASE; DIAGNOSTIC PERFORMANCE; SIGNAL-INTENSITY; HEPATIC NODULES; CIRRHOTIC LIVER; ACID;
D O I
10.1007/s11547-024-01879-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo perform an intra-individual comparison of LI-RADS category and imaging features in patients at high risk of hepatocellular carcinoma (HCC) on contrast-enhanced CT, gadoxetate disodium-enhanced MRI (EOB-MRI), and extracellular agent-enhanced MRI (ECA-MRI) and to analyze the diagnostic performance of each imaging modality.MethodThis retrospective study included cirrhotic patients with at least one LR-3, LR-4, LR-5, LR-M or LR-TIV observation imaged with at least two imaging modalities among CT, EOB-MRI, or ECA-MRI. Two radiologists evaluated the observations using the LI-RADS v2018 diagnostic algorithm. Reference standard included pathologic confirmation and imaging criteria according to LI-RADS v2018. Imaging features were compared between different exams using the McNemar test. Inter-modality agreement was calculated by using the weighted Cohen's kappa (k) test.ResultsA total of 144 observations (mean size 34.0 +/- 32.4 mm) in 96 patients were included. There were no significant differences in the detection of major and ancillary imaging features between the three imaging modalities. When considering all the observations, inter-modality agreement for category assignment was substantial between CT and EOB-MRI (k 0.60; 95%CI 0.44, 0.75), moderate between CT and ECA-MRI (k 0.46; 95%CI 0.22, 0.69) and substantial between EOB-MRI and ECA-MRI (k 0.72; 95%CI 0.59, 0.85). In observations smaller than 20 mm, inter-modality agreement was fair between CT and EOB-MRI (k 0.26; 95%CI 0.05, 0.47), moderate between CT and ECA-MRI (k 0.42; 95%CI -0.02, 0.88), and substantial between EOB-MRI and ECA-MRI (k 0.65; 95%CI 0.47, 0.82). ECA-MRI demonstrated the highest sensitivity (70%) and specificity (100%) when considering LR-5 as predictor of HCC.ConclusionsInter-modality agreement between CT, ECA-MRI, and EOB-MRI decreases in observations smaller than 20 mm. ECA-MRI has the provided higher sensitivity for the diagnosis of HCC.
引用
收藏
页码:1575 / 1586
页数:12
相关论文
共 50 条
  • [41] Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine
    Daniel Stocker
    Stefanie Hectors
    Octavia Bane
    Naik Vietti-Violi
    Daniela Said
    Paul Kennedy
    Jordan Cuevas
    Guilherme M. Cunha
    Claude B. Sirlin
    Kathryn J. Fowler
    Sara Lewis
    Bachir Taouli
    European Radiology, 2021, 31 : 9306 - 9315
  • [42] Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System
    Yang, Jie
    Jiang, Hanyu
    Xie, Kunlin
    Bashir, Mustafa R.
    Wan, Haifeng
    Huang, Jiayan
    Qin, Yun
    Chen, Jie
    Lu, Qiang
    Song, Bin
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
  • [43] The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI
    Pan, Junhan
    Song, Mengchen
    Yang, Lili
    Zhao, Yanci
    Zhu, Yanyan
    Wang, Meng
    Chen, Feng
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5801 - 5811
  • [44] Inter-rater agreement in the characterization of cystic renal lesions on contrast-enhanced MRI
    Seppala, Nicholas
    Kielar, Ania
    Dabreo, Dominique
    Duigenan, Shauna
    ABDOMINAL IMAGING, 2014, 39 (06): : 1267 - 1273
  • [45] Inter-rater agreement in the characterization of cystic renal lesions on contrast-enhanced MRI
    Nicholas Seppala
    Ania Kielar
    Dominique Dabreo
    Shauna Duigenan
    Abdominal Imaging, 2014, 39 : 1267 - 1273
  • [46] Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system
    Kim, Tae Kyoung
    Noh, Seung Yeon
    Wilson, Stephanie R.
    Kono, Yuko
    Piscaglia, Fabio
    Jang, Hyun-Jung
    Lyshchik, Andrej
    Dietrich, Christoph F.
    Willmann, Juergen K.
    Vezeridis, Alexander
    Sirlin, Claude B.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (04) : 280 - 289
  • [47] CT, MRI and contrast-enhanced ultrasound features of mucinous cystic neoplasm of the liver
    Rius, Emily
    Dautry, Raphael
    Tzedakis, Stylianos
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2025, 106 (02) : 79 - 80
  • [48] Data-Driven Modification of the LI-RADS Major Feature System on Gadoxetate Disodium-Enhanced MRI: Toward Better Sensitivity and Simplicity
    Jiang, Hanyu
    Song, Bin
    Qin, Yun
    Wei, Yi
    Konanur, Meghana
    Wu, Yuanan
    Zaki, Islam H.
    McInnes, Matthew D. F.
    Lafata, Kyle J.
    Bashir, Mustafa R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 55 (02) : 493 - 506
  • [49] Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma
    Kim, Dong Hwan
    Choi, Sang Hyun
    Koo, Boyeon
    Choi, Se Jin
    Jang, Hyeon Ji
    Heo, Subin
    Byun, Jae Ho
    Won, Hyung Jin
    Shin, Yong Moon
    EUROPEAN RADIOLOGY, 2025,
  • [50] Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI-CEUS) in Oncology
    Schwarze, Vincent
    Rubenthaler, Johannes
    Marschner, Constantin
    Fabritius, Matthias Philipp
    Rueckel, Johannes
    Fink, Nicola
    Puhr-Westerheide, Daniel
    Gresser, Eva
    Froelich, Matthias Frank
    Schnitzer, Moritz Ludwig
    Grosse Hokamp, Nils
    Afat, Saif
    Staehler, Michael
    Geyer, Thomas
    Clevert, Dirk-Andre
    CANCERS, 2020, 12 (10) : 1 - 17